日本局部晚期头颈部鳞状细胞癌治疗模式与医疗资源利用数据集

数据集获取（Figshare）

• 源站标题：Data Sheet 1_Treatment patterns, outcomes, healthcare resource utilization, and costs associated with locally advanced squamous cell carcinoma of the head and neck in Japan.docx
• DOI：10.3389/fonc.2025.1607280.s001
• 发布日期：2025-09-04
• 文件数：1 个
• 文件总体积：136.47 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Treatment_patterns_outcomes_healthcare_resource_utilization_and_costs_associated_with_locally_advanced_squamous_cell_carcinoma_of_the_head_and_neck_in_Japan_docx/30052312

命令行下载

curl -L -o "Data Sheet 1_Treatment patterns, outcomes, healthcare resource utilization, and costs associated with locally advanced squamous cell carcinoma of the .docx" "https://ndownloader.figshare.com/files/57666865"

文件清单

• Data Sheet 1_Treatment patterns, outcomes, healthcare resource utilization, and costs associated with locally advanced squamous cell carcinoma of the .docx（136.47 KB）

文件总体积 136.47 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

ObjectiveTreatment patterns and healthcare resource utilization (HCRU) data in patients with locally advanced (stage III to IVB) squamous cell carcinoma of the head and neck (LA SCCHN) in Japan are limited. This study describes the patient demographics and characteristics, treatment patterns, HCRU, and costs among Japanese patients with newly diagnosed LA SCCHN.
MethodsThis longitudinal, observational, retrospective study was conducted using real-world medical claims data from the Medical Data Vision Co., Ltd. database in Japan (1 January 2015–31 July 2022). Patients aged ≥18 years at the index date (first date of locally advanced head and neck cancer [HNC] diagnosis) and having a confirmed diagnosis of HNC during 01 January 2016–30 June 2021 in the oral cavity, larynx, hypopharynx, or oropharynx (based on ICD-10 diagnostic codes) were included. Baseline demographic and clinical characteristics were collected during the pre-index period. Treatment patterns, HCRU, and associated costs were reported during the post-index period.
ResultsOf the included 6741 patients with LA SCCHN, 51.3% received definitive nonsurgical treatment, 32.4% underwent primary resection, and 16.1% did not receive any agent. The most common chemotherapy agent used for chemoradiotherapy was cisplatin (74.7%). Docetaxel, cisplatin, and 5-fluorouracil combination (TPF) was used as induction chemotherapy for 28.6% of patients who received induction treatment followed by surgery and in 55.6% of patients who received induction treatment followed by radiotherapy. Patients receiving primary resection were typically older than those receiving definitive nonsurgical treatment for each cancer site and stage. Almost all patients had ≥1 all-cause hospitalizations with substantial HCRU-associated costs.
ConclusionsThis real-world study demonstrates that treatment of patients with LA SCCHN in Japan often included definitive nonsurgical treatment or primary surgery. The substantial burden related to LA SCCHN-associated HCRU and considerable percentage of patients receiving no treatment highlights a need for novel and effective therapies for LA SCCHN.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fonc.2025.1607280.s001（source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Treatment_patterns_outcomes_healthcare_resource_utilization_and_costs_associated_with_locally_advanced_squamous_cell_carcinoma_of_the_head_and_neck_in_Japan_docx/30052312）。